Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06988709 · ClinicalTrials.gov registry record · NA
Examining the Most Effective Method to Reduce Running Ground Contact Time
A NA study of Healthy Runners, sponsored by Keller Army Community Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06988709: Recruiting NA study of Healthy Runners, sponsored by Keller Army Community Hospital.
NCT06988709 is a NA study of Healthy Runners that is actively recruiting participants, run by Keller Army Community Hospital. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06988709, a NA study of Healthy Runners, is actively recruiting participants, sponsored by Keller Army Community Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of our study is to establish the most effective running retraining technique to decrease ground contact time. This will be investigated by applying three running retraining conditions and assessing the change in ground contact time and other biomechanical variables between the runner's baseline running and each retraining technique.
Primary Outcome
The amount of time in milliseconds that the foot remains in contact with the ground while running. GCT will be measured through the RunScribe device.
Conditions Studied
Interventions
- OTHER Real-time Visual Feedback
- OTHER Real-time Auditory Feedback
- OTHER Real-time Verbal Feedback
Study Locations (1)
New York
- Keller Army Community Hospital - West Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT06988709 shows while recruiting
NCT06988709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Healthy Runners appearing as the primary indexed condition, and to 3 interventions - of which Real-time Visual Feedback is the first listed.
NCT06988709 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06988709 about?
NCT06988709 is a clinical study titled "Examining the Most Effective Method to Reduce Running Ground Contact Time". The purpose of our study is to establish the most effective running retraining technique to decrease ground contact time. This will be investigated by applying three running retraining conditions and assessing the change in ground contact time and other biomechanical variables between the runner's b...
What is the current status of trial NCT06988709?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-05-01. Estimated completion is 2026-12-01.
What conditions does trial NCT06988709 study?
This clinical trial studies the following conditions: Healthy Runners.
What interventions are being tested in trial NCT06988709?
The interventions under investigation include: Real-time Visual Feedback (OTHER), Real-time Auditory Feedback (OTHER), Real-time Verbal Feedback (OTHER).
Who is sponsoring clinical trial NCT06988709?
This trial is sponsored by Keller Army Community Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06988709 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06988709's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI